HIV antigen-antibody combination enzyme immunoassay - The experience of a London teaching hospital

Journal of Medical Virology

Volumn 79, Issue SUPPL. 1, 2007, Pages

  Goldenberg, Simon ^a   Kulasegaram, Ranjababu ^a   Peters, Barry ^a,b   Panayotakopoulos, George ^a,b   Tong, C Y William ^a,b  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

HIV antigen antibody combination EIA; Primary HIV infection; Sero conversion

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GAG PROTEIN; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN;

ANTIGEN ANTIBODY REACTION; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENZYME IMMUNOASSAY; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RATE; NONHUMAN; RETROSPECTIVE STUDY; SCREENING TEST; SEROCONVERSION; TEACHING HOSPITAL; UNITED KINGDOM;

EID: 34748895718     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.20964     Document Type: Conference Paper

References (10)

1. Brust S, Duttmann H, Feldner J, Gurtler L, Thorstensson R, Simon F. 2000. Shortening of the diagnostic window with a new combined HIV p24 antigen and anti-HIV-1/2/0 screening test. J Virol Methods 90:153-165.
2. Health Protection Agency. 2006. Communicable Disease in London 2002-05. A Review by the Health Protection Agency in London.
3. Hecht FM, Wang L, Collier A, Little S, Markowitz M, Margolick J, Kilby JM, Daar E, Conway B, Holte S. AIEDRP Network. 2006. A multicenter observational study of the potential benefits of initiating combination antiretroviral therapy during acute HIV infection. J Infect Dis 194:725-733.
4. Ly TD, Edlinger C, Vabret A. 2000. Contribution of combined detection assays of p24 antigen and anti-human immunodeficiency virus (HIV) antibodies in diagnosis of primary HIV infection by routine testing. J Clin Microbiol 38:2459-2461.
5. McElborough D. 2004. Importance of using an HIV Ag/Ab combined assay in a UK population at high risk of acquiring HIV infection. Commun Dis Public Health 7:312-314.
6. Rice PS, Cybulska B, Parry JV, Rowland-Jones S, Daniels RS. 1999. Reappearance of HIV antibody in an infected, seronegative individual after treatment with highly active antiretroviral therapy. AIDS 13:729-731.
7. Saville RD, Constantine NT, Cleghorn FR, Jack N, Bartholomew C, Edwards J, Gomez P, Blattner WA. 2001. Fourth-generation enzyme-linked immunosorbent assay for the simultaneous detection of human immunodeficiency virus antigen and antibody. J Clin Microbiol 39:2518-2524.
8. Van Binsbergen J, Siebelink A, Jacobs A, Keur W, Bruynis F, van de Graaf M, van der Heijden J, Kambel D, Toonen J. 1999. Improved performance of seroconversion with a 4th generation HIV antigen/antibody assay. J Virol Methods 82:77-84.
9. Weber B. 2002. Fourth generation human immunodeficiency virus (HIV) screening assays with an improved sensitivity for p24 antigen close the second diagnostic window period in primary HIV infection. J Clin Virol 25:357-359.
10. Weber B, Fall EHM, Berger A, Doerr HW. 1998. Reduction of diagnostic window by new fourth-generation human immunodeficiency virus screening assays. J Clin Microbiol 36:2235-2239.